Release Date: October 31, 2024
Expiration Date: October 31, 2025
Time to Complete Activity: 1.0 hour
Faculty
Raymond K. Cross, MD
Director, Inflammatory Bowel and Colorectal Disease Center
Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy Medical Center
Adjunct Professor of Medicine
University of Maryland School of Medicine
Baltimore, MD
Millie D. Long, MD, MPH
Professor of Medicine
Director, Gastroenterology and Hepatology Fellowship Program
University of North Carolina at Chapel Hill
Chapel Hill, NC
Target Audience
This activity has been designed to address the educational needs of gastroenterology specialists, including physicians and advanced practice providers (PAs, nurse practitioners).
Educational Provider
| This activity is provided by Paradigm Medical Communications, LLC. |
 |
| |
|
| In collaboration with American Gastroenterology Association (AGA). |
 |
Supporter Acknowledgment
This activity is supported by an educational grant from Takeda Pharmaceuticals USA, Inc.
Program Overview
Experts review recent developments in the management of inflammatory bowel disease (IBD), and, using relevant case scenarios, engage in robust discussion to contextualize these developments with a focus on the management of IBD in the presence of comorbid conditions or contraindications.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Select appropriate evidence-based, guideline-aligned treatment for IBD
- Develop individualized treatment plans for patients with IBD based on patient characteristics
- Outline factors to consider in the management of patients with IBD and comorbidities using shared decision-making
Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Paradigm requires that all planners, faculty, and others who are in a position to control the content of this activity disclose all financial relationships with ineligible companies during the past 24 months.
All relevant relationships are identified and mitigated according to Paradigm policy prior to individuals assuming their roles and are disclosed prior to learners’ engagement in the activity. Paradigm is committed to providing learners with high-quality accredited continuing education that promotes improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The content of this activity was independently reviewed to ensure that it is fair and balanced, scientifically rigorous, evidence based, and aligned with the public interest. All relevant relationships have been mitigated.
Raymond K. Cross, MD
Advisor: AbbVie Inc.; Bristol-Myers Squibb Company; Fresenius Kabi AG; Janssen Pharmaceuticals, Inc; Magellan Health, Inc.; Option Care Health Inc; Pfizer Inc; Pharmacosmos A/S; Samsung Bioepis; Sandoz Group AG; Sebela Pharmaceuticals
Speakers Bureau: Bristol-Myers Squibb Company
Research Funding: Janssen Pharmaceuticals, Inc
Other (Scientific Co-Director): CorEvitas, LLC
Other (Executive Committee Member): IBD Education Group
Millie D. Long, MD, MPH
Consultant: AbbVie Inc.; Bristol-Myers Squibb Company; Eli Lilly and Company; Intercept; Janssen Pharmaceuticals, Inc; Pfizer Inc; Prometheus Laboratories; Takeda Pharmaceutical Company Ltd; Target RWE
Research Funding: Eli Lilly and Company; Pfizer Inc; Takeda Pharmaceutical Company Ltd
Paradigm Medical Communications, LLC staff members have no relevant financial relationships with ineligible companies to disclose.
AGA staff members have no relevant financial relationships with ineligible companies to disclose.
Peer Reviewer
Advisor: Bristol-Myers Squibb Company (expired 5/23); Johnson & Johnson Services, Inc. (expired 8/24)
Consultant: AbbVie Inc. (expired 10/23); Astellas Pharma Inc. (expired 7/24)
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.
Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC must ensure that its activities include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.
Privacy policy
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com .
© 2024 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.
Agenda
| Presentation Topic/Title |
| Session 1 |
Eosinophilic Esophagitis |
| |
Management of Barrett's Esophagus and GERD in 2024 |
| |
| EGID |
| |
Workup and Management of Gastroparesis |
| |
Colorectal Cancer Screening |
| |
IBS and Approaching Non-IBS Mimickers |
| |
| Session 2 - Breakouts |
| Breakout A |
| |
Non-IBD Colitis |
|
Understanding Esophageal and Anorectal Manometry Interpretation |
|
Management of Acute GI Bleed |
| |
| Session 3 |
| |
Management of Cirrhosis |
| |
Acute Liver Failure |
|
A Evaluation of Abnormal LFTs |
| |
MAFLD and MASH |
| |
Screening and Management of HCC Update on Liver Transplantation |
|
| Session 4 - Tracks |
| Early Career Track |
| |
Getting Started as an APP in GI
(What I Wish I Would've Known!) |
|
Nutrition in GI |
|
Clinical Application for the New APP
(Consults/ SOAP notes and Communication) |
| |
| Advanced APP Track |
| |
Get Cultured
Update on Management of H. pylori and C. diff |
|
Professional Development for the APP: Cultivating a Career Outside the Clinic |
|
Addressing Nutritional Concerns in IBD |
| |
| Session 5 - IBD |
| |
IBD Basics: Review of Ulcerative Colitis and
Crohn’s Disease |
| |
IBD Pharmacology: Positioning of Therapy |
|
Health Maintenance |
| |
Integration of APPs in IBD Care |
| |
IBD Case Study Symposium |
Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 1.0 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Hardware/Software Requirements
This accredited CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers (Desktop/Mobile)
The latest releases of the following browsers are supported:
- Chrome
- Firefox
- Microsoft Edge (Chromium)
- Safari
- Opera
- Brave
PDF documents
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here: http://get.adobe.com/reader
Technical Support: If you have any technical problems or playback issues, email us contactus@paradigmmc.com.
Instructions for Participation
To receive a certificate of participation, participants must:
- Follow instructions to register or log in with your professional information and complete the pretest
- View the online activity in its entirety
- Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
For questions regarding CME credit, contact the Paradigm CME Department at cme@paradigmmc.com.
There are no fees for participating in this activity.
Accreditation and designation statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AGA Institute designates this live activity for a maximum of 17 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and mitigate all conflicts of interest prior to delivering the educational activity to learners.
